Construction work on Songdo Vaccine Raw Material Manufacturing Plant located in Incheon, South Korea commenced in Q1 2024, after the project was announced in Q4 2021. According to GlobalData, who tracks and profiles more than 220,000 major construction projects from announcement to completion, the project is expected to be completed by Q4 2025. To learn more about the Songdo Vaccine Raw Material Manufacturing Plant project, buy the profile here.
The project involves the construction of a vaccine raw material manufacturing plant in Sangdo, Incheon, South Korea.
Smarter leaders trust GlobalData
The project includes the following:
1. Construction of a production unit
2. Construction of a laboratory
3. Construction of an administrative office
4. Construction of a distribution unit
5. Construction of research facilities
6. Construction of warehouses
7. Construction of cell culture media
8. Construction of membranes
9. Construction of disposable bags
10. Installation of related machinery
11. Installation of safety and security systems
Construction on the project is expected to be completed by Q4 2025.
For more details on the Songdo Vaccine Raw Material Manufacturing Plant project, buy the profile here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying research used to produce this article.
GlobalData’s Construction Projects database tracks over 220,000 new construction projects valued at >$25m from announcement to completion across all countries and sectors.
